Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 44

Results For "PAS"

794 News Found

ERES IV acquires a majority stake in Oncodesign Services
News | October 27, 2022

ERES IV acquires a majority stake in Oncodesign Services

Oncodesign Services (ODS ), with 600 clients in 33 countries and 227 employees worldwide, provides services from target identification to hit-to-lead and lead optimization through to IND filing.


USFDA approves Imjudo in combination with Imfinzi for liver cancer
Drug Approval | October 26, 2022

USFDA approves Imjudo in combination with Imfinzi for liver cancer

Approval based on HIMALAYA Phase III trial results which showed single priming dose of Imjudo added to Imfinzi reduced risk of death by 22% vs. sorafenib


Lupin to acquire two inhalation brands from Sunovion for US$75 million
News | October 20, 2022

Lupin to acquire two inhalation brands from Sunovion for US$75 million

The acquisition of these two brands expands Lupin's portfolio of inhalation products in the U.S.


BJ Wadia Children's Hospital and Cipla Foundation launches pediatric palliative home care services
Healthcare | October 15, 2022

BJ Wadia Children's Hospital and Cipla Foundation launches pediatric palliative home care services

The hospital has taken a huge step by offering “Titli-palliative care services at home” to provide curative, restorative, and life-prolonging treatment to seriously ill children


DKSH acquires two ear care brands
News | October 14, 2022

DKSH acquires two ear care brands

DKSH has signed an agreement to acquire two ear care brands from Noru Pharma for Australia, New Zealand, and selected markets in Asia.


Intuitive India unveils ‘Xi experience centre
Healthcare | October 14, 2022

Intuitive India unveils ‘Xi experience centre

Xi Experience centre is aimed at familiarizing and bringing awareness about robotic-assisted surgery among the surgical fraternity in the country


Merck recognized on Fortune’s 2022 change the World List
News | October 12, 2022

Merck recognized on Fortune’s 2022 change the World List

This recognition marks the third time in five years that Merck has been included on Fortune’s Change the World list.


Ashland announces Klucel xtend HPC matrix former for extended-release tablets
News | October 11, 2022

Ashland announces Klucel xtend HPC matrix former for extended-release tablets

The need for hot-melt extrusion (HME) polymers is expected to grow as the pharma industry moves to implement more continuous and sustainable processes.


Thermo Fisher Scientific emphasizes on the need for more disruptive technologies
Medical Device | October 09, 2022

Thermo Fisher Scientific emphasizes on the need for more disruptive technologies

Thermo Fisher is working closely with large pharmaceutical businesses to develop companion diagnostics in multiple areas such as heart disease, neurosciences and infectious diseases.


ICON selected by BARDA to conduct anthrax vaccine clinical trial
Diagnostic Center | October 09, 2022

ICON selected by BARDA to conduct anthrax vaccine clinical trial

This clinical study will inform operational logistics and use of AV7909 should an anthrax emergency occur.